Stockscreener 앱 받기
1.24
4.62%
-0.06
시간 외 거래:
1.22
-0.02
-1.61%
Indaptus Therapeutics Inc 주식(INDP)의 최신 뉴스
Short Interest in Indaptus Therapeutics, Inc. (NASDAQ:INDP) Increases By 140.5% - Defense World
Cybin (NYSEAMERICAN:CYBN) Shares Down 4.4% - Defense World
Japan Tobacco Inc. (OTCMKTS:JAPAY) Short Interest Update - Defense World
Sei Investments Co. Has $17.72 Million Position in Teradata Co. (NYSE:TDC) - Defense World
Indaptus Therapeutics (NASDAQ:INDP) Stock Price Down 9.2% - Defense World
Intelligent Bio Solutions Inc. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results and Operational Highlights - Marketscreener.com
Intelligent Bio Solutions Inc. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results and Operational Highlights - StockTitan
Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences Holdings Corp. (NASDAQ: IART) and Encourages Long-Term IART Shareholders to Contact the Firm - Business Wire
The Escalator: Imre, Kyverna Therapeutics, The Bloc and more - MM+M Online
StockNews.com Downgrades Independent Bank (NASDAQ:INDB) to Sell - Defense World
Integrated BioPharma (OTCMKTS:INBP) Trading Down 2.2% - Defense World
Indivior PLC REMINDER – INDV Stockholders Should Contact - GlobeNewswire
IBTX stock hits 52-week high at $60.77 amid robust growth - Investing.com
INDV Investors Have Opportunity to Lead Indivior PLC Securities Fraud Lawsuit - PR Newswire
Northland Capmk Equities Analysts Cut Earnings Estimates for Indivior PLC (NASDAQ:INDV) - MarketBeat
Holdings of Intelligent Bio Solutions Inc (INBS) are aligned with the stars - SETE News
Upward Trajectory: Intelligent Bio Solutions Inc (INBS) Posts a Gaine, Closing at 2.48 - The Dwinnex
Imunon (NASDAQ:IMNN) Shares Up 5.6% - Defense World
INDV Investors Have Opportunity to Lead Indivior PLC Securities Fraud Lawsuit - Longview News-Journal
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Indivior PLC of Class Action Lawsuit and Upcoming DeadlinesINDV - PR Newswire
Financial Health Check: Examining Indivior Plc (INDV)’s Key Ratios - The Dwinnex
Class Action Lawsuit Against Indivior PLC (NASDAQ:INDV) - TipRanks
Ready to Jump After Recent Trade: Indivior Plc (INDV) - SETE News
Indivior PLC Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsINDV - PR Newswire
Intelligent Bio Solutions Inc’s: Contrasting Stock Performances in a Volatile Market - The InvestChronicle
DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value - GlobeNewswire
Technical analysis of Intelligent Bio Solutions Inc (INBS) stock chart patterns - US Post News
Negative FDA AdCom vote on Ocaliva - The Pharma Letter
The Gross Law Firm Reminds Indivior Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 1, 2024INDV - PR Newswire
Piper Sandler Reaffirms “Overweight” Rating for Indivior (NASDAQ:INDV) - Defense World
INDV SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Indivior PLC Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
Indivior PLC (NASDAQ:INDV) Shares Sold by Royal London Asset Management Ltd. - MarketBeat
INVESTOR ALERT: DiCello Levitt LLP Shareholder Class Action - GlobeNewswire
Indivior's (INDV) Overweight Rating Reiterated at Piper Sandler - MarketBeat
Intl Paper Co stock hits 52-week high at $49.25 amid market rally By Investing.com - Investing.com South Africa
In the Green: Indivior Plc (INDV) Closes at 9.62, Up/Down 0.42 from Previous Day - The Dwinnex
INmune Bio stock dips on $13M securities offering - MSN
INDP stock touches 52-week low at $1.55 amid market challenges - Investing.com Canada
INDP stock touches 52-week low at $1.55 amid market challenges - Investing.com UK
Indaptus Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
Intec Pharma Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020 - Marketscreener.com
INDP Stock Earnings: Indaptus Therapeutics Beats EPS for Q2 2024 - InvestorPlace
Indaptus Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update - wallstreet:online
Indaptus Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update - StockTitan
Insider Buyers Lose US$41k As Indaptus Therapeutics Sheds US$1.2m - Simply Wall St
Insider Buyers Lose US$41k As Indaptus Therapeutics Sheds US$1.2m - Yahoo Finance
Indaptus Therapeutics Inc expected to post a loss of 54 cents a shareEarnings Preview - XM
Virtu Financial LLC Makes New $32,000 Investment in Indaptus Therapeutics, Inc. (NASDAQ:INDP) - Defense World
Indaptus raises $3 million through stock and warrants sale By Investing.com - Investing.com Australia
Indaptus raises $3 million through stock and warrants sale - Investing.com
Indaptus Therapeutics, Inc. Announces $3.0 Million Registered Direct Offering and Concurrent Private Placement - StockTitan
Indaptus Therapeutics to Participate in Tribe Public Webinar On Wednesday, March 20, 2024 - Quantisnow
Registration Is Now Open For Tribe Public's Webinar Event "Immunotherapy Reimagined" Featuring Indaptus Therapeutics' CEO On Friday, September 29, 2023 - Quantisnow
Indaptus Therapeutics, Inc. (NASDAQ:INDP) Short Interest Update - Defense World
Barclays Begins Coverage on Kodiak Gas Services (NYSE:KGS) - American Banking and Market News
Short Interest in Indaptus Therapeutics, Inc. (NASDAQ:INDP) Grows By 9.6% - Defense World
Short Interest in Indaptus Therapeutics, Inc. (NASDAQ:INDP) Grows By 9.6% - American Banking and Market News
Indaptus (INDP) Surges on Upbeat Pre-Clinical Decoy Data - Yahoo New Zealand News
Q2 2024 EPS Estimates for Indaptus Therapeutics, Inc. Boosted by Analyst (NASDAQ:INDP) - Defense World
Virtu Financial LLC Makes New $572000 Investment in StoneCo Ltd. (NASDAQ:STNE) - Defense World
Apollomics, Inc. (NASDAQ:APLMW) Short Interest Update - Defense World
Indaptus Therapeutics, Inc. (NASDAQ:INDP) Sees Significant Decline in Short Interest - Defense World
HC Wainwright Reaffirms “Buy” Rating for Indaptus Therapeutics (NASDAQ:INDP) - Defense World
eClinical Solutions to Highlight Successful Approaches for AI-Driven Clinical Trial Productivity at Citeline Roundtable, DIA, and More - Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market SessionBioCardia (NASDAQ:BCDA), Adlai Nortye (NASDAQ ... - Benzinga
Indaptus Therapeutics Elects Directors and Approves Key ProposalsTipRanks.com - TipRanks
Indaptus reports positive Phase 1 trial results for cancer treatment By Investing.com - Investing.com Australia
Indaptus reports positive Phase 1 trial results for cancer treatment - Investing.com India
Indaptus reports positive Phase 1 trial results for cancer treatment By Investing.com - Investing.com
European Patent Office Approves Key Patent for Indaptus Therapeutics' Platform Technology - Quantisnow
Indaptus reports positive Phase 1 trial results for cancer treatment - Investing.com
0.05%
4.86%
자본화:
|
볼륨(24시간):